CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.
October 31st 2024
Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung cancer.
October 18th 2024
Newly-Approved Lorbrena Shows Better Responses in Patients With Brain Metastases
March 31st 2021The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Compared to previously-approved options, experts say Lorbrena is more effective.
Opdivo With or Without Yervoy Did Not Prolong Survival in Small Cell Lung Cancer
March 29th 2021Previously, treatments for patients with extensive-disease small cell lung cancer were limited with a poor prognosis. Researchers sought to investigate if Opdivo plus Yervoy or Opdivo alone would improve survival.
FDA Fast Track of Novel Drug May Open Doors for Certain Patients with Non-Small Cell Lung Cancer
March 15th 2021The FDA’s fast track designation to poziotinib for use in previously treated patients with non-small cell lung cancer whose disease harbors a certain genetic mutation, may open the doors to an accelerated approval.
The Future of Adoptive Cellular Therapy in Lung Cancer
March 15th 2021In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.
'A Breath of Fresh Air': FDA's Cosela Approval May Improve Quality of Life in Lung Cancer
March 12th 2021The FDA’s recent approval of Cosela to reduce the frequency of chemotherapy-induced bone marrow suppression in adults who are receiving certain types of chemotherapy for extensive-stage small cell lung cancer is a “breath of fresh air,” according to an expert.
Looking at the Big Picture of Small Cell Lung Cancer
March 10th 2021An expert discusses ways that small cell lung cancer is diagnosed, how to treat it and how to pivot if the disease spreads or recurs. He also focuses on efforts in the clinical trial space to potentially treat patients more effectively.
FDA, Drug Manufacturer Pull Keytruda’s Indication for Small Cell Lung Cancer
March 5th 2021Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.
Organization Urges That Patients With Lung Cancer Worldwide Have Access to COVID-19 Vaccine
March 5th 2021The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in urging leading public health officials to prioritize administering the COVID-19 vaccine to cancer survivors and patients undergoing treatment for the disease.
Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing
February 9th 2021CURE will host a webinar, sponsored by Amgen, in which panelists from several cancer organizations will discuss ways to improve awareness around biomarker testing, improve coordination of care for patients with lung cancer and remove barriers to access to care.